Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma
| Autor: | J. Puente Vázquez, N. García Miralles, Miguel Martín, José A. García-Sáenz, C. Bueno Muiño, Andrés Sánchez-Pernaute, J. Sastre Valera, Eduardo Díaz-Rubio |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Oncology
Adult Male Cancer Research medicine.medical_specialty medicine.medical_treatment Locally advanced Antineoplastic Agents Docetaxel Adenocarcinoma Gastric adenocarcinoma Stomach Neoplasms Internal medicine medicine Humans Pathological Neoadjuvant therapy Complete response Chemotherapy business.industry General Medicine Neoadjuvant Therapy Chemotherapy Adjuvant Disease Progression Taxoids business Adjuvant medicine.drug |
| Zdroj: | Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 9(5) |
| ISSN: | 1699-048X |
| Popis: | Locally advanced gastric adenocarcinoma has a poor outcome. Neoadjuvant treatment is being tested in locally advanced non-resectable tumours and in those resectable tumours with a high risk of recurrence. Efforts to identify prognostic factors and more active and less toxic preoperative regimens are being searched for. We report the case of a patient achieving a complete histopathological complete response following docetaxel- based neoadjuvant chemotherapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink